Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
Paying to Sponsor an Ocean
A small island in the Pacific is offering people the chance to help protect its waters by becoming a sponsor of the ocean.
Load More